Actively Recruiting
Studying Synbiotic Therapy Effects on Kidney Function in Adults with Chronic Kidney Disease Stages III-IV A Double-Blind Placebo-Controlled Trial
Led by Chittagong Medical College · Updated on 2026-11-03
96
Participants Needed
1
Research Sites
8 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating the effects of synbiotic therapy on kidney function in adults with chronic kidney disease CKD at stages III and IV. CKD is a growing global health issue, particularly in low and middle-income countries like Bangladesh. This study evaluates whether combining probiotics and prebiotics can improve kidney function by restoring gut bacterial balance and reducing inflammation linked to CKD progression. Participants will be randomly assigned to receive either synbiotic therapy or a placebo capsule daily for three months, alongside standard CKD care following KDIGO guidelines. The synbiotic capsule contains specific strains of beneficial bacteria and prebiotic fibers. Clinical and lab assessments will be conducted at the start, after 1.5 months, and at the end of the three-month treatment period to compare the effects. During the study, participants will have their kidney function measured by serum creatinine, estimated glomerular filtration rate eGFR, and blood urea nitrogen BUN. Inflammatory markers like C-reactive protein CRP and gastrointestinal symptoms will also be tracked using a rating scale. Safety and any adverse effects will be monitored. The total study duration is about one and a half years, including recruitment and follow-up.
CONDITIONS
Brief Title
Effect of Synbiotic Therapy on Renal Function Outcomes in Patients With Chronic Kidney Disease Stage III-IV: A Double-blind Randomized Placebo-controlled Trial.
Research Team
M
Md Rezwanul Haque, MBBS
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here